Larimar Therapeutics
Latest round
- Series E
Last raised
- Dec 2013
Total raised
- $126M
Investors
- 7
About Larimar Therapeutics
, formerly known as ZafGen Inc. (Nasdaq: LRMR), develops therapeutics for the treatment of metabolic disorders and type 2 diabetes. In September 2022, Larimar Therapeutics, Inc.15 per share on the NASDAQ. Larimar's portfolio includes a proprietary intracellular delivery platform. This technology is designed to transport proteins and other critical molecules directly into target cells, addressing deficiencies at the root of rare diseases. The platform's versatility allows Larimar to engineer tailored fusion proteins designed to address specific biochemical deficits associated with various rare conditions. Additionally, CTI-1601 is under Phase 1 clinical trial, aiming to restore frataxin levels and potentially alleviate symptoms, marking a significant stride in rare disease treatment.
Who invested in Larimar Therapeutics
7 investors across 6 rounds
See all investors in Larimar Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Larimar Therapeutics
Who invested in Larimar Therapeutics?
Larimar Therapeutics has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Larimar Therapeutics raised?
Larimar Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Larimar Therapeutics last raise money?
Larimar Therapeutics's most recent round on record is a Series E, in Dec 2013.
What does Larimar Therapeutics do?
, formerly known as ZafGen Inc.
Where is Larimar Therapeutics headquartered?
Larimar Therapeutics is headquartered in Bala Cynwyd, US.
Which VCs invest in companies like Larimar Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Larimar Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Larimar Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.